abstract |
Immunological composition comprising a purified and isolated OspA antigen from Borrelia burgdorferi or a vector that expresses it and at least one additional antigen from a mammalian pathogen other than Borrelia burgdorferi, or a vector that expresses at least one additional antigen, and optionally a Pharmaceutically or veterinarily acceptable vehicle; wherein, the additional antigen is an adenovirus antigen; or wherein, the additional antigen is a combination of a canine distemper antigen, an adenovirual antigen, a coronavirus antigen, a parainfluenza antigen, and a parvovavirus antigen. |